In accordance with the recent change
in the U.S. patent system under the American Inventors Protection
Act, the United States Patent and Trademark Office (USPTO) made
application available before it is patented. Published applications
are important reference materials for patent examiners and a valuable
resource to the public. For more information, please check USPTO
announcement.
Click on the Application number to view the full text and images
of the application. This service is provided by the U.S.
Patent and Trademark Office web site.
|
20030033621 |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
9/28/01 |
2/13/03 |
|
20030032673 |
Therapeutic strategies for prevention and treatment of alzheimer's disease |
7/19/02 |
2/13/03 |
|
20030032070 |
Methods for diagnosing and treating alzheimer's disease and parkinson's disease |
7/19/02 |
2/13/03 |
|
20030023997 |
Transgenic C. Elegans as a Model Organism for Investigations on Alzheimer's Disease |
10/21/99 |
1/30/03 |
|
20030013881 |
Compounds to treat Alzheimer's disease |
9/21/01 |
1/16/03 |
|
20030013699 |
Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject |
5/22/02 |
1/16/03 |
|
20030013648 |
Peptides for the treatment of Alzheimer's disease and other b-amyloid protein fibrillogenesis disorders |
9/24/01 |
1/16/03 |
|
20020197737 |
NOVEL METHODS FOR TESTING INHIBITORS OF PAIRED HELICAL FILAMENTS AND USES FOR TREATMENT OF ALZHEIMER'S DISEASE |
9/7/99 |
12/26/02 |
|
20020197652 |
Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same |
6/25/02 |
12/26/02 |
|
20020193317 |
Steroidal sapogenins and their derivatives for treating alzheimer's disease |
2/15/02 |
12/19/02 |
|
20020192725 |
Relation of apolipoprotein E genotype and estrogen deprivation in alzheimer's disease |
6/26/02 |
12/19/02 |
|
20020192243 |
Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
6/19/02 |
12/19/02 |
|
20020188106
|
Novel tools for the diagnosis and treatment of Alzheimer's disease |
2/4/02 |
12/12/02 |
|
20020188012 |
Method for treating Alzheimer's disease |
2/8/02 |
12/12/02 |
|
20020183379 |
Kits for determining risk of Alzheimer's disease |
7/14/02 |
12/5/02 |
|
20020182152 |
Ocular diagnosis of Alzheimer's Disease |
4/25/02 |
12/5/02 |
|
20020177614 |
Methods for treating nuerodegenerative diseases including Alzheimer's |
3/23/01 |
11/28/02 |
|
20020174447 |
Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of Alzheimer's Disease |
1/23/01 |
11/21/02 |
|
20020174446 |
Identification of genes involved in alzheimer's disease using drosophila melanogaster |
9/27/01 |
11/21/02 |
|
20020172676 |
Method of treatment of alzheimer's disease and device therefor |
5/16/01 |
11/21/02 |
|
20020168753 |
In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases |
11/30/01 |
11/14/02 |
|
20020165124 |
Poly-L-Lysine dissolves fibrillar aggregation of the alzheimer b-amyloid peptide in vitro |
5/4/01 |
11/7/02 |
|
20020164668 |
Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
4/3/01 |
11/7/02 |
|
20020162129 |
Prevention and treatment of alzheimer's disease |
7/9/01 |
10/31/02 |
|
20020160425 |
Process for differential diagnosis of Alzheimer's dementia and device therefor |
10/4/01 |
10/31/02 |
|
20020151506 |
Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders |
3/15/02 |
10/17/02 |
|
20020150948 |
Antibody PTI-HS7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease |
11/2/01 |
10/17/02 |
|
20020150878 |
Method for the diagnosis of Alzheimer's Disease and other prion related disorders |
1/17/02 |
10/17/02 |
|
20020150637 |
Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereof |
3/26/02 |
10/17/02 |
|
20020143240 |
Methods for diagnosing Alzheimer's disease and other forms of dementia |
3/29/01 |
10/3/02 |
|
20020143177 |
Compounds to treat alzheimer's disease |
6/29/01 |
10/3/02 |
| 20020137112
|
Compositions and methods for diagnosing alzheimer's disease |
12/7/00 |
9/26/02 |
|
20020137108 |
CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease |
11/8/01 |
9/26/02 |
|
20020133834 |
Test and model for alzheimer's disease |
2/16/01 |
9/19/02 |
|
20020133019 |
Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
8/24/01 |
9/19/02 |
|
20020132281 |
Secretases related to alzheimer's dementia |
11/1/01 |
9/19/02 |
|
20020131932 |
Radiopharmaceuticals for diagnosing alzheimer's disease |
11/6/01 |
9/19/02 |
|
20020129391 |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
9/28/01 |
9/12/02 |
|
20020128255 |
Compounds to treat Alzheimer's Disease |
6/29/01 |
9/12/02 |
|
20020127541 |
Alzheimer's related proteins and methods of use |
2/8/02 |
9/12/02 |
|
20020119934 |
Methods for using specific saccharides for treating Alzheimer's disease and other amyloidoses |
4/29/02 |
8/29/02 |
|
20020114792 |
a-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
1/23/02 |
8/22/02 |
|
20020111384 |
Method of treating Alzheimer's Disease |
10/15/01 |
8/15/02 |
|
20020111365
|
Hydroxyethyl ureas as inhibitors of alzheimer's b-amyloid production |
8/10/01 |
8/15/02 |
|
20020107213 |
Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E |
4/16/01 |
8/8/02 |
|
20020104108 |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
9/28/01 |
8/1/02 |
|
20020104104 |
METHOD FOR IDENTIFYING ALZHEIMER'S DISEASE THERAPEUTICS USING TRANSGENIC ANIMAL MODELS |
9/8/98 |
8/1/02 |
|
20020102594 |
Diagnostic methods for Alzheimer's disease by detection of multiple mRNAs |
1/16/02 |
8/1/02 |
|
20020102594 |
Diagnostic methods for Alzheimer's disease by detection of multiple mRNAs |
1/16/02 |
8/1/02 |
|
20020102553 |
Molecular markers for the diagnosis of alzheimer's disease |
1/25/01 |
8/1/02 |
|
20020102259 |
Methods and compositions for stimulating CD 45 and thereby suppressing microglial activation associated with Alzheimer's disease |
11/5/01 |
8/1/02 |
|
20020098520 |
Cell tests and diagnostic index for alzheimer's disease |
10/9/01 |
7/25/02 |
|
20020098481 |
METHOD OF DETERMINING ALZHEIMER'S DISEASE RISK USING APOLIPOPROTEIN E4 GENOTYPE ANALYSIS IN COMBINATION WITH DECREASED ESTROGEN LEVELS |
10/22/99 |
7/25/02 |
|
20020094999 |
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
2/7/02 |
7/18/02 |
|
20020094335 |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
5/29/01 |
7/18/02 |
|
20020086067 |
Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
12/29/00 |
7/4/02 |
|
20020086009 |
ANTI-PHOSPHORYLATED TAU PROTEIN ANTIBODIES AND METHODS FOR DETECTING ALZHEIMER`S DISEASE WITH THE USE OF THE SAME |
4/19/99 |
7/4/02 |
|
20020082273 |
Agents for use in the treatment of alzheimer's disease |
9/21/01 |
6/27/02 |
|
20020081634 |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
4/5/01 |
6/27/02 |
|
200200720500 |
Secretases related to Alzheimer's dementia |
2/28/01 |
6/13/02 |
|
20020064819
|
Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
2/27/01 |
5/30/02 |
|
20020064500 |
Radiotracers for in vivo study of acetylcholinesterase and alzheimer's disease |
4/28/00 |
5/30/02 |
|
20020060630 |
System for monitoring patients with alzheimer's disease or related dementia |
11/1/01 |
5/23/02 |
|
20020058637 |
Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer's disease and tau-protein kinase I |
5/30/01 |
5/16/02 |
|
20020055529 |
Method for treating Alzheimer's Disease |
6/26/01 |
5/9/02 |
|
20020052373 |
Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
8/16/01 |
5/2/02 |
|
20020051988 |
Methods for diagnosing and treating alzheimer's disease |
5/29/01 |
5/2/02 |
|
20020048764 |
Human PEM as a target for birth contol and treatment of Alzheimer's disease |
5/31/01 |
4/25/02 |
|
20020048746 |
Model for alzheimer's disease and other neurodegenerative diseases |
7/31/01 |
4/25/02 |
|
20020037315 |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
2/27/01 |
3/28/02 |
|
20020035263 |
Novel arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives |
9/18/01 |
3/21/02 |
|
20020035145 |
Methods for treating neuropsychiatric disorders |
4/13/01 |
3/21/02 |
|
20020031497 |
Porcine neural cells and their use in treatment of neurological deficits due
to neurodegenerative diseases |
4/26/01 |
3/14/02 |
|
20020028462 |
Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's disease |
8/10/01 |
3/7/02 |
|
20020025944 |
Use of clioquinol for the therapy of Alzheimer's disease |
10/10/01 |
2/28/02 |
|
20020025527 |
Methods and assays for diagnosing alzheimer's disease |
7/3/01 |
2/28/02 |
|
20020022650 |
Method of modulating microglial activation for the treatment of acute and
chronic neurodegenerative disorders |
7/5/01 |
2/21/02 |
|
20020022621 |
Benzodiazepinone beta -amyloid inhibitors: arylacetamidoalanyl derivatives |
7/2/01 |
2/21/02 |
|
20020022242 |
Diagnostic test for alzheimer's disease |
4/9/01 |
2/21/02 |
|
20020019992 |
TRANSGENIC NON-HUMAN MAMMALS WITH PROGRESSIVE NEUROLOGIC DISEASE |
3/2/99 |
2/14/02 |
|
20020016978 |
TRANSGENIC ANIMAL EXPRESSING NON-NATIVE WILD-TYPE AND FAMILIAL ALZHEIMER'S
DISEASE MUTANT PRESENILIN 1 PROTEIN ON NATIVE PRESENILIN 1 NULL BACKGROUND |
5/14/98 |
2/7/02 |
|
20020010172 |
Lactams as inhibitors of A-beta protein production |
3/27/01 |
1/24/02 |
|
20020009461 |
Porcine neural cells and their use in treatment of neurological deficits due
to neurodegenerative diseases |
5/2/01 |
1/24/02 |
|
20020006959 |
Use of medium chain triglycerides for the treatment and prevention of
Alzheimer's Disease and other diseases resulting from reduced Neuronal
Metabolism |
5/1/01 |
1/17/02 |
|
20020006627 |
Method for diagnosis of Alzheimer's disease |
1/31/01 |
1/17/02 |
|
20020006606 |
MLK inhibitors for the treatment of neurological disorders |
6/21/01 |
1/17/02 |
|
20020004522 |
Compounds active at a novel site on receptor-operated calcium channels
useful for treatment of neurological disorders and diseases |
4/2/01 |
1/10/02 |
|
20020004194 |
Assays and methods of diagnosis and treatment based on use of sodium
channels as targets for amyloid beta or its aggregates |
12/21/00 |
1/10/02 |
|
20020002270 |
PURIFIED ANTIGEN FOR ALZHEIMER'S DISEASE, AND METHODS OF OBTAINING
AND USING SAME |
6/16/99 |
1/3/02 |
|
20020002199 |
MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) |
3/11/99 |
1/3/02 |
|
20020002178 |
Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]- pyridines
as cyclin dependent kinase inhibitors |
4/24/01 |
1/3/02 |
|
20010055630 |
Compostion and methods for treating alzheimer's disease and other
amyloidoses |
8/24/01 |
12/27/01 |
|
20010051642 |
Method for treating Alzheimer's disease |
1/29/01 |
12/13/01 |
|
20010051633 |
Subtype-selective NMDA receptor ligands and the use thereof |
2/7/01 |
12/13/01 |
|
20010047032 |
Polyhydroxylated aromatic compounds for the treatment of amyloidosis
and alpha-synuclein fibril diseases |
12/26/00 |
11/29/01 |
|
20010044126 |
Predictive diagnostic for alzheimer's disease |
12/29/00 |
11/22/01 |
|
20010036949 |
Pharmaceutical composition and method of treatment of diseases
of cognitive dysfunction in a mammal |
1/16/01 |
11/1/01 |
|
20010034884 |
Abeta-peptide screening assay |
2/27/01 |
10/25/01 |
|
20010028895 |
Methods of treating alzheimer's disease |
2/2/01 |
10/11/01 |
|
20010027309 |
Therapeutic method for treatment of alzheimer's disease |
6/1/01 |
10/4/01 |
|
20010026916 |
DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE BY DETECTION OF MULTIPLE
MRNAS |
10/30/98 |
10/4/01 |
|
20010021526 |
Cellular and animal models for diseases associated with mitochondrial
defects |
4/2/01 |
9/13/01 |
|
20010021508 |
METHODS OF DIAGNOSING RENAL SALT WASTING SYNDROME AND ALZHEIMER'S
DISEASE AND METHODS OF TREATING THE SAME |
6/11/98 |
9/13/01 |
|
20010021391 |
Alzheimer's disease secretase, APP substrates therefor, and uses
therefor |
2/27/01 |
9/13/01 |
|
20010020097 |
N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS
COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE
RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
3/30/99 |
9/6/01 |
|
20010020028 |
Agents for treating neurodegenerative disorders |
2/6/01 |
9/6/01 |
|
20010018208 |
Alzheimer's disease secretase, APP substrates therefor, and uses
therefor |
2/28/01 |
8/30/01 |
|
20010016951 |
Transgenic animal model for alzheimer disease |
4/25/01 |
8/23/01 |
|
20010016324 |
Alzheimer's disease secretase, APP substrates therefor, and uses
therefor |
2/27/01 |
8/23/01 |
|
20010014670 |
TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE |
1/8/99 |
8/16/01 |
|
20010012626 |
Genetic alterations related to familial alzheimer's disease |
2/20/01 |
8/9/01 |
|
20010005753 |
6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-y-
l) chromane derivatives: dopamine receptor subtype specific ligands |
1/16/01 |
6/28/01 |
|
20010003799 |
Apparatus and method for adjunct (add-on) therapy for depression,
migraine, neuropsychiatric disorders, partial complex epilepsy,
generalized epilepsy and involuntary movement disorders utilizing
an external stimulator |
11/30/00 |
6/14/01 |
|
20010003741 |
Aminoalcohol derivative and medicament comprising the same |
12/5/00 |
6/14/01 |
|
20010001662 |
Neural transplantation using pluripotent neuroepithelial cells |
1/12/01 |
5/24/01 |
|
20010001100 |
Process for the isolation of galanthamine |
12/21/00 |
5/10/01 |
|
20010000075 |
Neurotactin and uses therefor |
12/1/00 |
3/29/01 |
Home
